Data from Targeted Assessment of G0S2 Methylation Identifies a Rapidly Recurrent, Routinely Fatal Molecular Subtype of Adrenocortical Carcinoma

MLA

Gary D. Hammer, et al. Data from Targeted Assessment of G0S2 Methylation Identifies a Rapidly Recurrent, Routinely Fatal Molecular Subtype of Adrenocortical Carcinoma. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.c.6527273.v1.

APA

Gary D. Hammer, Maria Candida B. V. Fragoso, Thomas J. Giordano, William E. Rainey, Suely K. N. Marie, Ana Claudia Latronico, Berenice B. Mendonca, Maria Claudia N. Zerbini, Beatriz M. P. Mariani, Juilee Rege, Michelle Vinco, Madson Q. Almeida, Bhramar Mukherjee, Tobias Else, Antonio Marcondes Lerario, & Dipika R. Mohan. (2023). Data from Targeted Assessment of G0S2 Methylation Identifies a Rapidly Recurrent, Routinely Fatal Molecular Subtype of Adrenocortical Carcinoma. https://doi.org/10.1158/1078-0432.c.6527273.v1

Chicago

Gary D. Hammer, Maria Candida B. V. Fragoso, Thomas J. Giordano, William E. Rainey, Suely K. N. Marie, Ana Claudia Latronico, Berenice B. Mendonca, et al. 2023. “Data from Targeted Assessment of G0S2 Methylation Identifies a Rapidly Recurrent, Routinely Fatal Molecular Subtype of Adrenocortical Carcinoma,” March. doi:10.1158/1078-0432.c.6527273.v1.